Investigational Vitiligo Medication Study

Now Enrolling Adults Age 18 and Older

Now Enrolling

About this research study

Vitiligo is an autoimmune disorder that causes patches of skin to lose pigment. Symptoms may include loss of pigment, itching, burning, and pain among emotional and physio-social impacts. Vitiligo can be unpredictable and lesions may remain stable, progress, or alternative between the two states throughout a person’s lifetime.

People with vitiligo may be eligible to join this research study of an investigational medication for the condition. Eligible participants may receive compensation for study-related time.

Eligible participants...

  • Must be age 18 and older
  • Must have been clinically diagnosed with vitiligo for at least 3 months and
    • Involvements at palms of the hands, soles of the feet, or dorsal aspect of the feet and
    • Involvement on the face (not including scalp, ears, neck, or surface area of the lips)
  • Must NOT currently have active forms of other disorders of pigmentation (coexistence of halo nevus/nevi is permitted)
  • May receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Row concave Shape Decorative svg added to top

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy